Remove Article Remove DEA Remove Pharmaceutical
article thumbnail

The Truth About Smoking Marijuana and Lung Health

Cannabis Cheri

They might even elaborate a bit and say that you are not likely to find a single patient in a hospital bed anywhere just because they use marijuana, but that’s another article. This article is all about the effects of marijuana on the lungs. Even though the JAMA study got significant media attention, it is nothing new under the sun.

Marijuana 246
article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.

DEA 51
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Truth About Smoking Marijuana and Lung Health

Cannabis Cheri

They might even elaborate a bit and say that you are not likely to find a single patient in a hospital bed anywhere just because they use marijuana, but that’s another article. This article is all about the effects of smoking marijuana and lung health. This post was originally published in 2017.

Marijuana 130
article thumbnail

DEA removes cannabis drug Epidiolex from controlled substances list

SMPL

GW Pharmaceuticals, a biopharmaceutical company based in London, saw its stock go up 5.9% The expansion comes two years after the DEA first took Epidiolex off the most-restrictive class of controlled substances. View the entire article here. Epidiolex, the only plant-derived cannabis drug approved by the U.S.

DEA 40
article thumbnail

And Here We Go Again! NASDAQ Article: Forget Cannabis: Psychedelic Medicine Is the Better Investing Opportunity

Cannabis Law Report

Any approved medicines will have to be rescheduled by the Drug Enforcement Administration (DEA). Back in 2018, the DEA rescheduled GW Pharmaceuticals ‘ (NASDAQ: GWPH) cannabis-based epilepsy medicine, Epidiolex, following its regulatory approval by the FDA. Fortunately, this issue shouldn’t be a show-stopper.

article thumbnail

GW Pharmaceuticals Wins the Queens Prize for Innovation

SpeedWeed

The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy for over 20 years—but also how much it so far has been reserved, as an industry, and as a drug, for the elite. GW Pharmaceuticals was just awarded a so-called “ Queen’s Prize for Innovation.” .

article thumbnail

CBD: Everything You Need to Know

CannaMD

Drugs, substances, and certain chemicals used to make drugs are classified into five categories (known as schedules ) depending on the Department of Drug Enforcement Agency (DEA)’s definition of the drug’s acceptable medical use and abuse/dependency potential. CBD Scheduling Rule Change. But the government is clear.

CBD 105